Patents by Inventor Jennifer C. Lee

Jennifer C. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transcutaneous analyte sensor systems and methods
    Patent number: 11992312
    Abstract: Sensor systems can be used to measure an analyte concentration. Sensor systems can include a base having a distal side configured to face towards a person's skin. An adhesive can couple the base to the skin. A transcutaneous analyte measurement sensor can be coupled to the base and can be located at least partially in the host. A transmitter can be coupled to the base and can transmit analyte measurement data to a remote device.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: May 28, 2024
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Minglian Shi, Sebastian Bohm, Maria Noel Brown Wells, John Patrick Majewski, Leah Morta Edra, Disha B. Sheth, John Michael Gray, Shanger Wang, Ted Tang Lee, Michael L. Moore, Jason Mitchell, Jennifer Blackwell, Neel Narayan Shah, Todd Andrew Newhouse, Jason Halac, Ryan Everett Schoonmaker, Paul V. Neale, Jiong Zou, Sean T. Saint
  • ANTI-ROR1 MACROCYCLIC PEPTIDES AND COMPOSITIONS
    Publication number: 20240116988
    Abstract: There are disclosed novel anti-ROR1 macrocyclic peptides and their conjugates with general structure of formula (I), which can be used as ROR1 inhibitors.
    Type: Application
    Filed: August 23, 2023
    Publication date: April 11, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: JENNIFER X. QIAO, VING G. LEE, TAMMY C. WANG, MICHAEL A. POSS
  • Substituted 6-azabenzimidazole compounds
    Patent number: 11925631
    Abstract: The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: March 12, 2024
    Assignee: Gilead Sciences, Inc.
    Inventors: Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman, Rao V. Kalla, Musong Kim, Seung H. Lee, Jennifer R. Lo, Jennifer A. Loyer-Drew, Scott A. Mitchell, Thao D. Perry, Gary B. Phillips, Patrick J. Salvo, Joshua J. Van Veldhuizen, Suet C. Yeung, Jeff Zablocki
  • FLUORESCENT BIOMOLECULE LABELING REAGENTS
    Publication number: 20080032409
    Abstract: The invention describes fluorescent biomolecule labeling reagents (I-SHark and phI-SHark) and their model compounds. Further described are methods of preparing and using the same.
    Type: Application
    Filed: August 7, 2007
    Publication date: February 7, 2008
    Applicant: California Institute of Technology
    Inventors: Jay R. Winkler, Jennifer C. Lee, Seth B. Harkins, Harry B. Gray